Cognition and motor control as a function of Δ9-THC concentration in serum and oral fluid:: Limits of impairment

被引:230
作者
Ramaekers, J. G. [1 ]
Moeller, M. R.
van Ruitenbeek, P.
Theunissen, E. L.
Schneider, E.
Kauert, G.
机构
[1] Maastricht Univ, Fac Psychol, Dept Neurocognit, Expt Psychopharmacol Unit, NL-6200 MD Maastricht, Netherlands
[2] Unikliniken Saarlandes, Hamburg, Germany
[3] Kriminaltechn Inst, Baden Wurttemberg, Germany
[4] Goethe Univ Frankfurt, Inst Legal Med, Dept Forens Toxicol, D-6000 Frankfurt, Germany
关键词
cannabis; serum; oral fluid; impairment; driving; THC threshold; forensics;
D O I
10.1016/j.drugalcdep.2006.03.015
中图分类号
R194 [卫生标准、卫生检查、医药管理];
学科分类号
摘要
Cannabis use has been associated with increased risk of becoming involved in traffic accidents; however, the relation between THC concentration and driver impairment is relatively obscure. The present study was designed to define performance impairment as a function of THC in serum and oral fluid in order to provide a scientific framework to the development of per se limits for driving under the influence of cannabis. Twenty recreational users of cannabis participated in a double-blind, placebo-controlled, three-way cross-over study. Subjects were administered single doses of 0, 250 and 500 mu g/kg THC by smoking. Performance tests measuring skills related to driving were conducted at regular intervals between 15 min and 6 h post smoking and included measures of perceptual-motor control (Critical tracking task), motor impulsivity (Stop signal task) and cognitive function (Tower of London). Blood and oral fluid were collected throughout testing. Results showed a strong and linear relation between THC in serum and oral fluid. Linear relations between magnitude of performance impairment and THC in oral fluid and serum, however, were low. A more promising way to define threshold levels of impairment was found by comparing the proportion of observations showing impairment or no impairment as a function of THC Concentration. The proportion of observations showing impairment progressively increased as a function of serum THC in every task. Binomial tests showed an initial and significant shift toward impairment in the Critical tracking task for serum THC concentrations between 2 and 5 ng/ml. At concentrations between 5 and 10 ng/ml approximately 75-90% of the observations were indicative of significant impairment in every performance test. At THC concentrations > 30 ng/ml the proportion of observations indicative of significant impairment increased to a full 100% in every performance tests. It is concluded that serum THC concentrations between 2 and 5 ng/ml establish the lower and upper range of a THC limit for impairment. (c) 2006 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:114 / 122
页数:9
相关论文
共 43 条
[31]   Antidepressants and driver impairment: Empirical evidence from a standard on-the-road test [J].
Ramaekers, JG .
JOURNAL OF CLINICAL PSYCHIATRY, 2003, 64 (01) :20-29
[32]   A study of the pharmacodynamic interaction between befloxatone and ethanol on performance and mood in healthy volunteers [J].
Ramaekers, JG ;
Muntjewerff, ND ;
Uiterwijk, MMC ;
vanVeggel, LMA ;
Patat, A ;
Durrieu, G ;
OHanlon, JF .
JOURNAL OF PSYCHOPHARMACOLOGY, 1996, 10 (04) :288-294
[33]  
Ramaekers JG, 2000, HUM PSYCHOPHARM CLIN, V15, P551, DOI 10.1002/1099-1077(200010)15:7<551::AID-HUP236>3.0.CO
[34]  
2-P
[35]   PLASMA-CONCENTRATIONS OF DELTA-9-TETRAHYDROCANNABINOL AND IMPAIRED MOTOR FUNCTION [J].
REEVE, VC ;
GRANT, JD ;
ROBERTSON, W ;
GILLESPIE, HK ;
HOLLISTER, LE .
DRUG AND ALCOHOL DEPENDENCE, 1983, 11 (02) :167-175
[36]  
Robbe H.W.J., 1994, INFLUENCE MARIJUANA
[37]   On-site testing of saliva and sweat with Drugwipe and determination of concentrations of drugs of abuse in saliva, plasma and urine of suspected users [J].
Samyn, N ;
van Haeren, C .
INTERNATIONAL JOURNAL OF LEGAL MEDICINE, 2000, 113 (03) :150-154
[38]   SPECIFIC IMPAIRMENTS OF PLANNING [J].
SHALLICE, T .
PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY OF LONDON SERIES B-BIOLOGICAL SCIENCES, 1982, 298 (1089) :199-209
[39]   Improved and validated method for the determination of Δ9-tetrahydrocannabinol (THC), 11-hydroxy-THC and 11-nor-9-carboxy-THC in serum, and in human liver microsomal preparations using gas chromatography-mass spectrometry [J].
Steinmeyer, S ;
Bregel, D ;
Warth, S ;
Kraemer, T ;
Moeller, MR .
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES, 2002, 772 (02) :239-248
[40]   Specific cognitive deficits in tests sensitive to frontal lobe dysfunction in obsessive-compulsive disorder [J].
Veale, DM ;
Sahakian, BJ ;
Owen, AM ;
Marks, IM .
PSYCHOLOGICAL MEDICINE, 1996, 26 (06) :1261-1269